GSK negotiating $1 billion sale of thrombosis drugs to Aspen
By Ben Hirschler LONDON (Reuters) - GlaxoSmithKline is discussing the sale of its thrombosis drug brands Arixtra and Fraxiparine, al...
Read More »
Contact Coast to Coast AM at 1-800-825-5033
By Ben Hirschler LONDON (Reuters) - GlaxoSmithKline is discussing the sale of its thrombosis drug brands Arixtra and Fraxiparine, al...
Read More »
By Kate Kelland LONDON (Reuters) - The marketing of unhealthy foods to children has proven "disastrously effective", driving obesity...
Read More »By Ben Hirschler LONDON (Reuters) - AstraZeneca has chosen a science park on the southern outskirts of Cambridge, England, next to t...
Read More »By Deena Beasley (Reuters) - Two long-awaited independent reviews of a controversial Medtronic Inc bone growth product show it works...
Read More »By Genevra Pittman NEW YORK (Reuters Health) - Watching and routinely examining men with early, slow-growing prostate cancer is more...
Read More »By Kate Kelland LONDON (Reuters) - Antibodies to a high-risk type of a virus that causes mouth and throat cancers when transmitted v...
Read More »By David Schwartz PHOENIX (Reuters) - Arizona's Republican Governor Jan Brewer signed a law on Monday to expand Medicaid, embracing ...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Increasing the number of hamburgers and other red meat people eat on a daily basis i...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Ouch: Boys know that toilet seats are an occupational hazard of potty training, but ...
Read More »By Myles Miller WILMINGTON, Delaware (Reuters) - A jury on Monday cleared a doctor of negligence in a lawsuit filed by a Delaware tr...
Read More »